» Articles » PMID: 25834433

Parameters and Characteristics Governing Cellular Internalization and Trans-barrier Trafficking of Nanostructures

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2015 Apr 3
PMID 25834433
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Cellular internalization and trans-barrier transport of nanoparticles can be manipulated on the basis of the physicochemical and mechanical characteristics of nanoparticles. Research has shown that these factors significantly influence the uptake of nanoparticles. Dictating these characteristics allows for the control of the rate and extent of cellular uptake, as well as delivering the drug-loaded nanosystem intra-cellularly, which is imperative for drugs that require a specific cellular level to exert their effects. Additionally, physicochemical characteristics of the nanoparticles should be optimal for the nanosystem to bypass the natural restricting phenomena of the body and act therapeutically at the targeted site. The factors at the focal point of emerging smart nanomedicines include nanoparticle size, surface charge, shape, hydrophobicity, surface chemistry, and even protein and ligand conjugates. Hence, this review discusses the mechanism of internalization of nanoparticles and ideal nanoparticle characteristics that allow them to evade the biological barriers in order to achieve optimal cellular uptake in different organ systems. Identifying these parameters assists with the progression of nanomedicine as an outstanding vector of pharmaceuticals.

Citing Articles

Nose-to-Brain Delivery of Biomimetic Nanoparticles for Glioblastoma Targeted Therapy.

Ferreira N, Leite C, Moreno N, Miranda R, Pincela Lins P, Rodero C ACS Appl Mater Interfaces. 2024; 17(1):484-499.

PMID: 39692595 PMC: 11783514. DOI: 10.1021/acsami.4c16837.


Recent Advances in the Development and Utilization of Nanoparticles for the Management of Malignant Solid Tumors.

Chavan D, Bhosale R, Thorat V, Shete A, Patil S, Tiwari D Cureus. 2024; 16(9):e70312.

PMID: 39469411 PMC: 11513206. DOI: 10.7759/cureus.70312.


Green synthesized silver nanoparticles, a sustainable approach for fruit and vegetable preservation: An overview.

Lieu M, Dang T, Nguyen T Food Chem X. 2024; 23:101664.

PMID: 39148528 PMC: 11324848. DOI: 10.1016/j.fochx.2024.101664.


Near-Infrared Emissive Super Penetrating Conjugated Polymer Dots for Intratumoral Imaging in 3D Tumor Spheroid Models.

Karabacak S, Coban B, Yildiz A, Yildiz U Adv Sci (Weinh). 2024; 11(35):e2403398.

PMID: 39023182 PMC: 11425279. DOI: 10.1002/advs.202403398.


Unveiling Nanoparticles: Recent Approaches in Studying the Internalization Pattern of Iron Oxide Nanoparticles in Mono- and Multicellular Biological Structures.

Petcov T, Straticiuc M, Iancu D, Mirea D, Trusca R, Mereuta P J Funct Biomater. 2024; 15(6).

PMID: 38921542 PMC: 11204647. DOI: 10.3390/jfb15060169.


References
1.
Geng Y, Dalhaimer P, Cai S, Tsai R, Tewari M, Minko T . Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol. 2008; 2(4):249-55. PMC: 2740330. DOI: 10.1038/nnano.2007.70. View

2.
Pelkmans L, Puntener D, Helenius A . Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science. 2002; 296(5567):535-9. DOI: 10.1126/science.1069784. View

3.
Vllasaliu D, Fowler R, Garnett M, Eaton M, Stolnik S . Barrier characteristics of epithelial cultures modelling the airway and intestinal mucosa: a comparison. Biochem Biophys Res Commun. 2011; 415(4):579-85. DOI: 10.1016/j.bbrc.2011.10.108. View

4.
Das M, Patil S, Bhargava N, Kang J, Riedel L, Seal S . Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials. 2007; 28(10):1918-25. PMC: 1913191. DOI: 10.1016/j.biomaterials.2006.11.036. View

5.
Jallouli Y, Paillard A, Chang J, Sevin E, Betbeder D . Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro. Int J Pharm. 2007; 344(1-2):103-9. DOI: 10.1016/j.ijpharm.2007.06.023. View